| Literature DB >> 34844561 |
Masato Shizuku1,2, Hiroyuki Kimura3, Hideya Kamei1, Shinichi Kishi4, Tatsuya Tokura4, Nobuhiko Kurata1, Kanta Jobara1, Atsushi Yoshizawa1, Chisato Tsuboi5, Naoko Yamaguchi5, Midori Kato4, Keita Kawai4, Makoto Yamashiki4, Emi Kanai4, Kanako Ishizuka4, Norio Ozaki4, Yasuhiro Ogura1.
Abstract
BACKGROUND: There are long-standing controversies about the transplant indications for alcoholic liver disease (ALD), because of the recognition that ALD is fundamentally self-inflicted. However, it is unclear whether psychosocial characteristics of ALD are different from that of non-alcoholic liver disease (NALD) in the selection of liver transplantation (LT) recipients. We aimed to clarify the psychosocial characteristics of ALD recipients (ALD-R)/ALD recipient candidates (ALD-RC) and NALD recipients (NALD-R)/ NALD recipient candidates (NALD-RC).Entities:
Keywords: Alcohol dependence; Alcoholic liver disease; Liver transplantation; Personality; Psychosocial functioning; Social support
Mesh:
Year: 2021 PMID: 34844561 PMCID: PMC8628411 DOI: 10.1186/s12876-021-02032-9
Source DB: PubMed Journal: BMC Gastroenterol ISSN: 1471-230X Impact factor: 3.067
Fig. 1Flow chart of participants enrolled in this study. Data were responses to questionnaires that were mailed to all subjects and returned to us. Statistical analysis was performed after excluding missing data. *Compared with published Japanese norms
Demographic characteristics of the ALD-RC and NALD-RC groups
| Variables | ALD-RC group ( | NALD-RC group ( | |
|---|---|---|---|
| Age (mean years, range) | 47.7 (37–60) | 46.8 (16–67) | 0.82 |
| Sex (Male/Female) | 11/8 | 26/30 | 0.29 |
| AST (IU/L) (mean, SD) | 52.1 (28.1) | 247.8 (1085.0) | 0.44 |
| ALT (IU/L) (mean, SD) | 27.8 (15.0) | 184.6 (763.5) | 0.39 |
| Hepatic encephalopathy (point, mean, SD) | 1.2 (0.4) | 1.3 (0.5) | 0.25 |
| Ascites (point, mean, SD)) | 1.8 (0.8) | 2.0 (0.9) | 0.48 |
| Total Bilirubin (mg/dL) (mean, SD) | 7.7 (7.3) | 8.6 (10.9) | 0.76 |
| Albumin (g/dL) | 2.9 (0.5) | 2.8 (0.7) | 0.58 |
| Prothrombin time (%) (mean, SD) | 46.5 (17.2) | 57.1 (20.9) | 0.10 |
| PT-INR (mean, SD) | 1.61 (0.4) | 1.51 (0.6) | 0.69 |
| Creatinine (mg/dL) (mean, SD) | 0.84 (0.4) | 1.07 (1.3) | 0.49 |
| MELD score (point) (mean, SD) | 18.1 (6.2) | 18.1 (10.2) | 0.93 |
| Child–Pugh score (point) (mean, SD) | 10.3 (1.7) | 9.9 (2.3) | 0.55 |
| Number of HCC (%) | 5 (26.3) | 5 (8.9) | 0.11 |
| Psychiatric disorders (Present/Absent) | 8/11 | 25/31 | 0.85 |
ALD-RC: Alcoholic liver disease recipient candidate; ALT: Alanine transaminase; AST: Aspartate transaminase; HCC: Hepatocellular carcinoma; NALD-RC: Non-alcoholic liver disease recipient candidate; MELD: Model for end-stage liver disease score; PT-INR: International normalized ratio of prothrombin time; SD: Standard deviation
The primary disease of the ALD-RC and NALD-RC
| ALD-RC (n = 19) | NALD-RC (n = 56) | |
|---|---|---|
| Alcoholic liver cirrhosis | 14 | 0 |
| Alcoholic liver cirrhosis with HCC | 5 | 0 |
| 0 | 9 | |
| Primary biliary cholangitis | 0 | 8 |
| Biliary atresia | 0 | 5 |
| Non-alcoholic steatohepatitis | 0 | 5 |
| Autoimmune hepatitis | 0 | 4 |
| Fulminant hepatitis | 0 | 4 |
| Hepatic C virus related cirrhosis | 0 | 3 |
| Polycystic liver disease | 0 | 3 |
| Hepatic B virus related cirrhosis with HCC | 0 | 3 |
| Hepatic B virus related cirrhosis | 0 | 2 |
| Hepatic C virus related cirrhosis with HCC | 0 | 2 |
| Wilson disease | 0 | 1 |
| Hepatic fibrosis | 0 | 1 |
| Idiopathic portal hypertension | 0 | 1 |
| Congenital biliary dilatation | 0 | 1 |
| Hypoplastic right hepatic lobe | 0 | 1 |
| Unknown | 0 | 3 |
ALD-RC, Alcoholic Liver Disease Recipient Candidate; HCC, Hepatic Cell Carcinoma; NALD-RC, Non-Alcoholic Liver Disease Recipient Candidate
A comparison of perioperative characteristics for ALD-R and NALD-R groups
| Variables | ALD-R group ( | NALD-R group ( | |
|---|---|---|---|
| Age (mean, range) | 52.3 (46–60) | 46.5 (16–67) | 0.31 |
| Sex (Male/Female) | 3/3 | 24/28 | 0.87 |
| MELD score (point) (mean ± SD) | 20.0 ± 8.6 | 17.9 ± 10.6 | 0.65 |
| Operation time (min) (mean ± SD) | 698 ± 53 | 757 ± 157 | 0.39 |
| Blood loss (ml) | 10,615 (4468) | 9295 (8353) | 0.77 |
| Donor type (Decease/Living) | 1/5 | 9/43 | 0.98 |
| Graft type (left/right/whole) | 1/4 /1 | 4/40/8 | 0.78 |
| Blood type (identical/compatible/incompatible) | 5/0/1 | 31/ 13/8 | 0.37 |
| Hospital stay (day) (mean, SD) | 79.0 (37.7) | 83.1 (79.9) | 0.90 |
| Follow up period (day) (mean, range) | 1160 (478–2150) | 1626 (107–3874) | 0.25 |
| Alive (%) | 5 (83.3) | 47 (90.4) | 0.61 |
| Dead (%) | 1 (16.7) | 5 (9.6) | |
| Clavien-Dindor classification Grade ≥ IIIb (%) | 3 (50.0) | 16 (30.8) | 0.39 |
ALD-R: Alcoholic liver disease recipient; MELD: Model for end-stage liver disease score; NALD-R: Non-alcoholic liver disease recipient; SD: Standard deviation
Comparison of psychosocial characteristics between ALD-RC group and NALD-RC group before liver transplantation
| Variables | ALD-RC | NALD-RC | t | df | r | |
|---|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | |||||
| VAS* | 14.28 (18.32) | 15.52 (20.52) | – | – | 0.87 | |
| AUDIT | 3.67 (6.06) | 1.65 (3.62) | 1.64 | 62 | 0.11 | |
| HADS | 9.83 (7.51) | 9.60 (6.59) | 0.12 | 58 | 0.90 | |
| BDI | 11.44 (9.49) | 9.07 (7.11) | 1.07 | 59 | 0.29 | |
| BEMIB | 28.33 (5.49) | 28.44 (4.80) | − 0.07 | 45 | 0.95 | |
| NP | 4.11 (1.84) | 4.82 (2.97) | − 0.94 | 60 | 0.35 | |
| SR | 5.24 (0.81) | 5.09 (1.22) | 0.47 | 58 | 0.64 | |
| Novelty Seeking | 8.63 (2.73) | 8.10 (2.57) | 0.67 | 53 | 0.50 | |
| Harm Avoidance | 11.38 (4.95) | 11.26 (4.04) | 0.09 | 53 | 0.93 | |
| Reward Dependence | 9.31 (1.99) | 10.11 (2.13) | − 1.27 | 51 | 0.21 | |
| Persistence | 2.24 (1.92) | 2.78 (1.53) | − 1.03 | 25 | 0.31 | |
| Self-Directedness | 14.19 (4.46) | 16.09 (5.14) | − 1.27 | 47 | 0.21 | |
| Cooperativeness | 17.47 (3.63) | 18.42 (3.21) | − 0.98 | 53 | 0.33 | |
| Self-Transcendence | 3.67 (2.95) | 3.62 (3.05) | 0.06 | 55 | 0.95 | |
| Care/Father | 15.31 (8.20) | 11.97 (9.62) | 1.22 | 53 | 0.23 | |
| Over-protection/Father | 29.00 (5.65) | 29.66 (6.73) | − 0.34 | 52 | 0.73 | |
| Care/Mother | 12.94 (8.34) | 8.08 (9.31) | 1.90 | 56 | 0.06 | |
| Over-protection/Mother | 23.41 (7.39) | 28.71 (7.69) | − 2.39 | 53 | 0.31 | |
| PCS | 26.84 (21.35) | 28.68 (17.85) | − 0.30 | 47 | 0.77 | |
| MCS | 49.80 (12.68) | 44.65 (11.34) | 1.36 | 47 | 0.18 | |
Bold value indicate p < 0.05
ALD-RC: Alcoholic liver disease recipient candidate; AUDIT: Alcohol Use Disorders Identification Test; BDI: Beck Depression Inventory; BEMIB, Brief Evaluation of Medication Influences and Beliefs; HADS: Hospital Anxiety and Depression Scale; NALD-RC: Non-alcoholic liver disease recipient candidate; PBI: Parental Bonding Instrument; SF-36: Medical Outcomes Study 36-Item Short Form Health Survey (PCS: Physical Component Summary; MCS: Mental Component Summary); SSQ: Social Support Questionnaire (NP: Number of Persons; SR: Satisfaction Rating); TCI: Temperament and Character Inventory; VAS: Visual Analogue Scale
*Mann–Whitney t test was used to evaluate the differences between two groups
A comparison of ALC-group and NALD-R group at 3 and 12 months after liver transplantation
| Variables | 3 months after liver transplantation | 12 months after liver transplantation | ||||
|---|---|---|---|---|---|---|
| ALD-R | NALD-R | ALD-R | NALD-R | |||
| n = 3 | n = 28 | n = 3 | n = 25 | |||
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |||
| AUDIT | 0.00 ± 0.00 | 0.46 ± 1.25 | 0.54 | 0.00 ± 0.00 | 0.33 ± 1.27 | 0.66 |
| HADS(T) | 3.67 ± 3.22 | 9.46 ± 7.31 | 0.19 | 2.00 ± 2.65 | 7.64 ± 7.33 | 0.20 |
| BDI | 8.67 ± 7.51 | 9.52 ± 8.03 | 0.86 | 4.67 ± 4.04 | 8.68 ± 7.66 | 0.39 |
| BEMIB | 33.33 ± 4.16 | 31.79 ± 4.34 | 0.56 | 34.00 ± 3.46 | 34.09 ± 3.04 | 0.96 |
| NP | 9.50 ± 6.30 | 4.67 ± 3.52 | 5.06 ± 1.01 | 4.35 ± 2.08 | 0.57 | |
| SR | 5.67 ± 0.58 | 5.06 ± 1.06 | 0.35 | 5.08 ± 0.12 | 5.17 ± 0.93 | 0.89 |
| PCS | 17.47 ± 28.25 | 26.03 ± 16.63 | 0.47 | 37.42 ± 10.93 | 43.80 ± 12.55 | 0.41 |
| MCS | 57.33 ± 14.03 | 54.22 ± 9.91 | 0.62 | 58.65 ± 6.77 | 53.77 ± 9.31 | 0.39 |
Bold value indicate p < 0.05
ALD-RC, Alcoholic Liver Disease Recipient Candidate; AUDIT, Alcohol Use Disorders Identification Test; BDI, Beck Depression Inventory; BEMIB, Brief Evaluation of Medication Influences and Beliefs; HADS, Hospital Anxiety and Depression Scale; NALD-RC, Non-Alcoholic Liver Disease Recipient Candidate; SF-36, The Medical Outcomes Study 36-item short form Health Survey (PCS, Physical Component Summary; MCS, Mental Component Summary); SSQ, Social Support Questionnaire (NP, Number of Persons; SR, Satisfaction Rating)
Fig. 2Comparison of SF-36 scores in ALD-R group and published Japanese norms. Although PCS scores in ALD-R were significantly lower than published Japanese norms preoperatively and at 12 months after transplantation, there was no significant difference in MCS scores at any time. ALD-R: Alcoholic liver disease recipient; MCS: Mental component summary; PCS: Physical component summary; SF-36: Short Form Health Survey